Muscle Cell-Enhanced Cartilage Tissue Engineering
Muscle Cell-Enhanced Cartilage Tissue Engineering
批准号:
8487368
负责人:
Li Zeng
金额:
$34.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2015-06-30
关键词:
AddressAdultAgingArthritisBiochemicalBiomechanicsCartilageCartilage MatrixCell DeathCell ProliferationChondrocytesChondrogenesisConditioned Culture MediaDevelopmentDevelopmental BiologyDiseaseEmbryoEmbryonic DevelopmentEngineeringGene ExpressionGoalsGrowthHomeostasisHumanHyaline CartilageImmunologyInflammationInflammatoryInflammatory Response PathwayInsulin-Like Growth Factor Binding Protein 5Insulin-Like Growth Factor IIJoint repairKnowledgeLeadMediatingMesenchymal Stem CellsMethodsModelingMuscleMuscle CellsNatural regenerationOrthopedicsPainPhysical environmentPhysiologicalPrevalenceProductionPropertyRegulationResearchResistanceRoleSeedsSignal PathwaySignal TransductionSilkSiteSocietiesSolutionsStimulusTNF geneTechnologyTestingTissue EngineeringTissuesUnited StatesWorkcartilage regenerationcell growthcell typeclinical applicationcytokinedisabilityeffective therapyimprovedinsightinterdisciplinary approachjoint destructionmeetingsnovelnovel strategiesphysical propertypublic health relevancerepairedresponsescaffoldtissue repair
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Arthritis is a leading cause of disability in the United States. Despite its prevalence in our ever-aging society, effective treatment options for arthritis are still limited. Arthritis is caused by the destruction of joint cartilage, which is accompanied by inflammation and pain. Cartilage tissue engineering offers a promising solution to regenerate cartilage and restore tissue function. However, the presence of pro-inflammatory cytokines at the host site inevitably leads to matrix degradation, causing the engineered cartilage to be unstable. Therefore, for this technology to be applied clinically there is a critical need to engineer stable cartilage that is resistant to pro-inflammatory cytokine-induced degradation. Our long-term goal is to gain critical knowledge of cartilage regulation and enhance the technology of cartilage tissue engineering for clinical applications. We are developing a novel strategy that integrates concepts and approaches from developmental biology with those of tissue engineering. During embryogenesis, muscle is one of the tissues that develop alongside the presumptive cartilage tissue. Our extensive preliminary studies indicate a role of muscle cells in regulating cartilage homeostasis and inflammatory stimuli. Our central hypothesis is that muscle cells and optimal scaffold selection can be used to enhance the stability of engineered cartilage by enhancing cartilage matrix production and the resistance to pro-inflammatory cytokines. We plan to test this hypothesis by using primary human articular chondrocytes and mesenchymal stem cells seeded in 3D silk scaffolds. We plan to: 1) investigate the role of muscle cells in regulating cartilage matrix production, 2) investigate the role of muscle cells in regulating the response to pro-inflammatory cytokines, and 3) investigate the effect of scaffold material on muscle cell regulation of cartilage matrix production and the response to pro-inflammatory cytokines. Our research team consists of experts in the fields of developmental biology, tissue engineering, immunology and orthopaedics. We believe that our synergistic efforts and interdisciplinary approach will result in deeper understanding of the regulation of cartilage homeostasis and the response to pro- inflammatory stimuli, providing the fundamental knowledge for modeling and treating arthritis. Thus, our study aspires to meet the critical need of improving tissue engineering technology, and may lead to the development of a novel strategy to engineer stable cartilage for clinical applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Wnt7a on Mast Cell-mediated inflammation associated with Alzheimer's Disease.
-
批准号:10726201
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2021
-
负责人:Li Zeng
-
依托单位:
Wnt7a-Mediated Competence to Resist Osteoarthritis Progression
-
批准号:10616688
-
项目类别:
-
资助金额:$58.73万
-
财政年份:2021
-
负责人:Li Zeng
-
依托单位:
Wnt7a-Mediated Competence to Resist Osteoarthritis Progression
-
批准号:10350647
-
项目类别:
-
资助金额:$58.8万
-
财政年份:2021
-
负责人:Li Zeng
-
依托单位:
Screening antibiotics using NIR fluorescence imaging for osteoarthritis treatment
-
批准号:9321990
-
项目类别:
-
资助金额:$18.15万
-
财政年份:2016
-
负责人:Li Zeng
-
依托单位:
Muscle Cell-Enhanced Cartilage Tissue Engineering
-
批准号:8691728
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2010
-
负责人:Li Zeng
-
依托单位:
Muscle Cell-Enhanced Cartilage Tissue Engineering
-
批准号:8040377
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2010
-
负责人:Li Zeng
-
依托单位:
Muscle Cell-Enhanced Cartilage Tissue Engineering
-
批准号:8298608
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2010
-
负责人:Li Zeng
-
依托单位:
Muscle Cell-Enhanced Cartilage Tissue Engineering
-
批准号:8135020
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2010
-
负责人:Li Zeng
-
依托单位:
Nkx3.2 nuclear localization and cartlidge formation
-
批准号:7193705
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2007
-
负责人:Li Zeng
-
依托单位:
Nkx3.2 nuclear localization and cartlidge formation
-
批准号:7615692
-
项目类别:
-
资助金额:$8.01万
-
财政年份:2007
-
负责人:Li Zeng
-
依托单位:
Nkx3.2 nuclear localization and cartlidge formation
-
批准号:7425955
-
项目类别:
-
资助金额:$8.01万
-
财政年份:2007
-
负责人:Li Zeng
-
依托单位:
Regulators of Cartilage Formation
-
批准号:6622346
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2002
-
负责人:Li Zeng
-
依托单位:
Regulators of Cartilage Formation
-
批准号:6445359
-
项目类别:
-
资助金额:$4.57万
-
财政年份:2002
-
负责人:Li Zeng
-
依托单位:
Regulators of Cartilage Formation
-
批准号:6721176
-
项目类别:
-
资助金额:$5.25万
-
财政年份:2002
-
负责人:Li Zeng
-
依托单位:
海外基金